Philip S. Portoghese Explained

Philip Salvatore Portoghese (born June 4, 1931) is an American medicinal chemist who has made notable contributions to the design and synthesis of ligands targeting opioid receptors. He is a Distinguished Professor of Medicinal Chemistry at the University of Minnesota, Twin Cities.[1] He also served as the Editor-in-chief of the Journal of Medicinal Chemistry from 1972 to 2012, when the job was taken on by his departmental colleague, Gunda I. Georg, who shares the Editor-in-chief position with Shaomeng Wang at the University of Michigan.[2]

Biography

Portoghese was born on June 4, 1931, in Brooklyn, New York. He received a B.S. in pharmacy at Columbia University and then went on to obtain an M.S. degree in physical pharmacy in 1958. He continued his graduate studies at the University of Wisconsin–Madison and obtained a Ph.D. in pharmaceutical chemistry under the mentorship of Edward E. Smissman in 1961. He joined the faculty of the Department of Medicinal Chemistry at University of Minnesota in 1961, where he has served with distinction for over five decades. He is known internationally for designing several opioid ligands including β-funaltrexamine,[3] naltrindole,[4] norbinaltorphimine,[5] and naltriben.[6] He has pioneered the use of bivalent ligands to target opioid receptor complexes called heteromers.[7] [8] [9] [10] He was honored in 2011 for 50 years of exemplary academic service by the University of Minnesota.[11] In 2007, he was inducted into the Hall of Fame of the American Chemical Society (ACS) Division of Medicinal Chemistry.[12] Portoghese served as Editor-in-chief of the Journal of Medicinal Chemistry from 1972 to 2012, making him one of the longest standing editors of an ACS journal.

Awards

Portoghese has been a recipient of numerous awards including:

External links

Notes and References

  1. Web site: Philip Portoghese - COP - Medicinal Chemistry - University of Minnesota . 2011-06-07 . https://web.archive.org/web/20110721230126/http://www.pharmacy.umn.edu/medchem/faculty/directory/faculty/portoghese/home.html . 2011-07-21 . dead .
  2. Web site: Editor. pubs.acs.org.
  3. 10.1021/jm00177a002 . 6245210 . A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activities . Journal of Medicinal Chemistry . 23 . 3 . 233–234 . 1980 . Portoghese . Philip S. . Larson . Dennis L. . Sayre . Lawrence M. . Fries . David S. . Takemori . A. E. .
  4. 10.1016/0014-2999(88)90502-X. 2832195. Naltrindole, a highly selective and potent non-peptide δ opioid receptor antagonist. European Journal of Pharmacology. 146. 1. 185–186. 1988. Portoghese. P.S.. Sultana. M.. Takemori. A.E..
  5. 2882399. 1987. Portoghese. P. S.. Binaltorphimine and nor-binaltorphimine, potent and selective kappa-opioid receptor antagonists. Life Sciences. 40. 13. 1287–92. Lipkowski. A. W.. Takemori. A. E.. 10.1016/0024-3205(87)90585-6.
  6. 1851833. 1991. Sofuoglu. M.. Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: Evidence for delta opioid receptor subtypes. The Journal of Pharmacology and Experimental Therapeutics. 257. 2. 676–80. Portoghese. P. S.. Takemori. A. E..
  7. 10.1021/jm00349a016. 7108900. Narcotic antagonistic potency of bivalent ligands which contain .beta.-naltrexamine. Evidence for simultaneous occupation of proximal recognition sites. Journal of Medicinal Chemistry. 25. 7. 847–849. 1982. Erez. M.. Takemori. A. E.. Portoghese. P. S..
  8. 10.1021/jm0342358 . 15163177 . A Bivalent Ligand (KDN-21) Reveals Spinal δ and κ Opioid Receptors Are Organized as Heterodimers That Give Rise to δ1andκ2Phenotypes. Selective Targeting of δ−κ Heterodimers . Journal of Medicinal Chemistry . 47 . 12 . 2969–2972 . 2004 . Bhushan . Rashmi G. . Sharma . Shiv K. . Xie . Zhihua . Daniels . David J. . Portoghese . Philip S. .
  9. 10.1073/pnas.0506627102 . 16365317 . 1323165 . Opioid-induced tolerance and dependence in mice is modulated by the distance between pharmacophores in a bivalent ligand series . Proceedings of the National Academy of Sciences . 102 . 52 . 19208–19213 . 2005 . Daniels . D. J. . Lenard . N. R. . Etienne . C. L. . Law . P.-Y. . Roerig . S. C. . Portoghese . P. S. . 2005PNAS..10219208D . free .
  10. Web site: NIDA - Publications - NIDA Notes - Vol. 22, No. 1 - Innovations . 2011-06-07 . https://web.archive.org/web/20110727103717/http://www.nida.nih.gov/NIDA_notes/NNvol22N1/Basic.html . 2011-07-27 . dead .
  11. Web site: Philip S. Portoghese Symposium - College of Pharmacy - University of Minnesota . 2011-06-07 . https://web.archive.org/web/20110721230151/http://www.pharmacy.umn.edu/news/portoghesesymp/home.html . 2011-07-21 . dead .
  12. Web site: ACS Division of Medicinal Chemistry.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Philip S. Portoghese".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.